KRYS
Krystal Biotech, Inc.
Stock
$322.28−3.03 (−0.93%)Close Oct 2, 2026
- Stock-based compensation, 2025
- $55M
- YoY, 2025
- +11.0%
- 5-year CAGR
- +75.5%
Stock-based compensation
Stock-based compensation by fiscal year
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $55M | +11.0% |
| 2024 | $49M | +23.0% |
| 2023 | $40M | +20.2% |
| 2022 | $33M | +116.9% |
| 2021 | $15M | +368.2% |
| 2020 | $3.3M | +164.1% |
| 2019 | $1.2M | +56.4% |
| 2018 | $792K | +222.0% |
| 2017 | $246K | +645.5% |
| 2016 | $33K | — |